[영어] - [한영]

등록자 : 관리자

업데이트 : 2020. 5. 31. 오전 7:10:05

01후65

As for a use invention for a medicament which requires the description of the pharmacological effects in the specification, if there is not a particular circumstance that the pharmacological mechanism showing the pharmacological effects has been clearly illuminated prior to the filing of the invention, the use invention is not regarded as being completed nor complying with the description requirements of the specification unless the specification includes working examples indicating pharmacological data, etc. showing that specific materials have such pharmacological effects, or is described clearly enough to take the place of them. Therefore, it is a change in the subject matter of the invention beyond the scope of the disclosure of the specification to add working examples not described in the original specification by making an amendment later.